Green Hygienics Holdings Inc. (GRYN)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Green Hygienics Holdings Inc. (GRYN) trades at $0.00 with AI Score 43/100 (Grade C). Green Hygienics Holdings, Inc. is a development stage company focused on the cultivation and processing of industrial hemp for cannabidiol (CBD) extraction. Market cap: $44, Sector: Healthcare.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for GRYN: GRYN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GRYN against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
GRYN: the 1 perspectives are evenly split.
How is this calculated? →Green Hygienics Holdings Inc. (GRYN) Healthcare & Pipeline Overview
Green Hygienics Holdings, Inc., operating in the specialty and generic drug manufacturing sector, focuses on cultivating and processing industrial hemp to extract cannabidiol (CBD). As a development stage company, Green Hygienics navigates the evolving regulatory landscape and competitive pressures within the burgeoning CBD market, while based in Poway, California.
What Is the Investment Thesis for GRYN?
Green Hygienics Holdings, Inc. presents a high-risk, high-reward investment opportunity, given its status as a development stage company in the volatile CBD market. The company's focus on cultivating and processing industrial hemp for CBD extraction aligns with the growing demand for CBD products. However, negative gross and profit margins of -14156.2% and -20488.8% respectively, indicate significant challenges in achieving profitability. Potential catalysts include securing key regulatory approvals and establishing strategic partnerships to expand market reach. The company's ability to scale operations efficiently and maintain cost competitiveness will be crucial for long-term success. Investors should carefully consider the risks associated with investing in a development stage company operating in a rapidly evolving and heavily regulated industry. The company's beta of -585.98 suggests an inverse correlation with the market, which may be unreliable given its OTC status and limited trading history.
Based on FMP financials and quantitative analysis
GRYN Key Highlights
- Green Hygienics Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
- The company is focused on the cultivation and processing of industrial hemp for cannabidiol (CBD) extraction.
- Green Hygienics Holdings, Inc. has a market capitalization of 44, indicating its small size and early stage of development.
- The company's negative P/E ratio of -0.00 and substantial negative profit margin of -20488.8% reflect its current lack of profitability.
- Green Hygienics Holdings, Inc. is headquartered in Poway, California, and employs 20 individuals.
Who Are GRYN's Competitors?
GRYN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GRYN's Key Strengths?
- Focus on a growing market (CBD).
- Cultivation and processing capabilities.
- Located in California, a major cannabis market.
What Are GRYN's Weaknesses?
- Development stage company with limited operating history.
- Negative profit and gross margins.
- Dependence on evolving regulations.
- Small size and limited resources.
What Could Drive GRYN Stock Higher?
- Potential regulatory approvals for hemp cultivation and CBD processing could significantly boost the company's prospects.
- Expansion of cultivation operations to increase production capacity and meet growing demand.
- Strategic partnerships with established retailers and distributors to expand market reach.
- Development and launch of new CBD product formulations to diversify revenue streams.
- Efforts to secure international distribution agreements to access new markets.
What Are the Key Risks for GRYN?
- Financial-distress signal — its Altman Z-Score of -20.04 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Evolving and uncertain regulations surrounding hemp and CBD could negatively impact the company's operations.
- Intense competition in the CBD market could limit the company's ability to gain market share.
- Fluctuations in hemp prices could affect the company's profitability.
- The company's development stage and negative profitability pose significant financial risks.
- The OTC Other tier designation indicates a higher level of risk compared to stocks listed on major exchanges.
What Are the Growth Opportunities for GRYN?
- Expansion into new CBD product categories represents a significant growth opportunity for Green Hygienics. The CBD market encompasses a wide range of products, including tinctures, topicals, edibles, and beverages. By diversifying its product offerings, Green Hygienics can target a broader customer base and increase its revenue streams. The market for CBD-infused beverages, for example, is projected to reach $1.4 billion by 2028, presenting a substantial opportunity for Green Hygienics to enter this emerging segment. Timeline: 2026-2028.
- Strategic partnerships with established retailers and distributors can accelerate Green Hygienics' market penetration. Collaborating with companies that have existing distribution networks and customer relationships can provide Green Hygienics with access to a wider audience and reduce its marketing and sales expenses. For example, partnering with a national pharmacy chain could significantly increase the visibility and availability of Green Hygienics' CBD products. Timeline: Ongoing.
- Developing proprietary CBD formulations and delivery methods can provide Green Hygienics with a competitive advantage. Investing in research and development to create unique and effective CBD products can differentiate the company from its competitors and attract customers seeking innovative solutions. For instance, developing a novel transdermal patch for targeted pain relief could appeal to a specific niche market. Timeline: 2027-2029.
- Expanding cultivation operations to increase production capacity is essential to meeting growing demand. As the CBD market expands, Green Hygienics will need to scale its cultivation operations to ensure a consistent supply of high-quality hemp. Investing in advanced cultivation techniques and technologies can improve yields and reduce production costs. The global hemp market is projected to reach $18.6 billion by 2027, underscoring the need for Green Hygienics to expand its production capacity. Timeline: Ongoing.
- Securing international distribution agreements can open up new markets for Green Hygienics' CBD products. The demand for CBD is growing globally, and expanding into international markets can significantly increase the company's revenue potential. However, navigating the regulatory complexities of different countries is crucial for success. For example, establishing a distribution partnership in Europe could provide access to a large and growing market for CBD products. Timeline: 2028-2030.
What Opportunities Does GRYN Have?
- Expansion into new CBD product categories.
- Strategic partnerships with retailers and distributors.
- Development of proprietary CBD formulations.
- Expansion into international markets.
What Threats Does GRYN Face?
- Intense competition in the CBD market.
- Evolving and uncertain regulations.
- Fluctuations in hemp prices.
- Potential for oversupply in the CBD market.
What Are GRYN's Competitive Advantages?
- Currently undefined, as the company is in the development stage.
- Potential for developing proprietary extraction methods for CBD.
- Potential for establishing strong relationships with hemp farmers for consistent supply.
- Potential for building a recognized brand in the CBD market, if successful.
What Does GRYN Do?
Green Hygienics Holdings, Inc. was founded in 2008 and is headquartered in Poway, California. Originally incorporated as Takedown Entertainment Inc., the company shifted its focus to the healthcare sector in July 2012, rebranding as Green Hygienics Holdings Inc. This strategic pivot centered on the cultivation and processing of industrial hemp, with the primary objective of extracting cannabidiol (CBD). As a development stage company, Green Hygienics is involved in the early phases of establishing its operations and market presence. The company's core business revolves around cultivating industrial hemp, a variety of the Cannabis sativa plant species grown specifically for industrial uses. Green Hygienics processes this hemp to extract CBD, a non-psychoactive compound that has gained significant attention for its potential therapeutic benefits. CBD is used in a wide array of products, including tinctures, topicals, edibles, and capsules. Green Hygienics aims to capitalize on the growing demand for CBD products by establishing a vertically integrated operation, encompassing cultivation, processing, and potentially, the manufacturing and distribution of finished goods. Green Hygienics is currently navigating the complexities of the evolving regulatory landscape surrounding hemp and CBD. The company's success hinges on its ability to secure necessary licenses, comply with evolving regulations, and establish efficient and scalable operations. As a relatively small player in a rapidly expanding market, Green Hygienics faces competition from both established agricultural companies and emerging cannabis businesses.
What Products and Services Does GRYN Offer?
- Cultivates industrial hemp, a specific variety of the Cannabis sativa plant.
- Processes harvested hemp to extract cannabidiol (CBD).
- Focuses on CBD extraction for use in various products.
- Operates as a development stage company, indicating early-stage business operations.
- Aims to capitalize on the growing market demand for CBD products.
- Navigates the regulatory landscape surrounding hemp and CBD cultivation and processing.
How Does GRYN Make Money?
- Cultivates industrial hemp as the primary raw material.
- Extracts CBD from the cultivated hemp using specialized processing techniques.
- Intends to sell or utilize the extracted CBD in various product formulations (specifics not detailed).
- Potentially aims for vertical integration, encompassing cultivation, processing, and product manufacturing.
What Industry Does GRYN Operate In?
Green Hygienics Holdings, Inc. operates within the rapidly evolving market for cannabidiol (CBD) products. The industry has experienced significant growth in recent years, driven by increasing consumer awareness of the potential therapeutic benefits of CBD and the legalization of hemp cultivation in many jurisdictions. However, the market is also characterized by intense competition, evolving regulations, and uncertainty regarding the long-term demand for CBD products. Green Hygienics competes with a range of companies, from established agricultural businesses to specialized cannabis firms. The company's success will depend on its ability to differentiate itself through product quality, branding, and efficient operations.
Who Are GRYN's Key Customers?
- Currently undefined, as the company is in the development stage.
- Target customers are likely manufacturers of CBD-infused products.
- Future customers may include consumers directly, pending product development and distribution strategies.
Company Profile
Green Hygienics Holdings Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Poway, US. The company is led by CEO Todd Mueller. GRYN has traded publicly since 2011.
F-Score 3/9Financial Health
Green Hygienics Holdings Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -20.04 places it in the distress zone, a signal of elevated financial risk.
ROE 149%Key Financial Metrics
Return on equity for Green Hygienics Holdings Inc. stands at 148.8%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.06 means current liabilities exceed short-term assets, a liquidity point worth watching.
GRYN Valuation & Market Position
With a 44 market cap, Green Hygienics Holdings Inc. sits in the micro-cap segment of the market. Relative to its peer group, GRYN's quantitative score of 43/100 is below the peer average of 66/100.
GRYN Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Focus on a growing market (CBD).
- Cultivation and processing capabilities.
- Located in California, a major cannabis market.
- Upcoming: Potential regulatory approvals for hemp cultivation and CBD processing could significantly boost the company's prospects.
Bear Case
- Development stage company with limited operating history.
- Negative profit and gross margins.
- Dependence on evolving regulations.
- Small size and limited resources.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
GRYN Latest News
No recent news available for GRYN.
GRYN Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GRYN.
Price Targets
Wall Street price target analysis for GRYN.
GRYN MoonshotScore
What does this score mean?
The MoonshotScore rates GRYN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Todd Mueller
CEO
Information on Todd Mueller's specific background and career history is not available. As CEO of Green Hygienics Holdings Inc., he is responsible for managing the company's overall strategy and operations. His leadership is crucial for guiding the company through its development stage and navigating the challenges of the CBD market. He is currently managing 20 employees.
Track Record: Due to limited information available on Todd Mueller's prior roles and Green Hygienics' early stage, a comprehensive track record cannot be established. His success will be measured by the company's ability to achieve profitability, secure regulatory approvals, and establish a sustainable market position.
GRYN OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Green Hygienics Holdings Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQB or OTCQX. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports, leading to increased information asymmetry and risk for investors. This tier is distinct from NYSE or NASDAQ listings, which have stringent listing requirements and provide greater transparency and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in Green Hygienics.
- Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- The company's development stage and negative profitability add to the investment risk.
- The OTC Other tier designation indicates a higher level of risk compared to stocks listed on major exchanges.
- The lack of analyst coverage and institutional interest can contribute to price volatility.
- Verify the company's legal standing and registration.
- Obtain and review any available financial statements.
- Assess the company's management team and their experience.
- Research the company's business model and competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Check for any regulatory filings or legal proceedings involving the company.
- The company's incorporation in 2008 suggests some level of operational history.
- The company's focus on the CBD market aligns with a growing industry.
- The company's headquarters in Poway, California, provides a physical presence.
- The company has 20 employees.
Common Questions About GRYN (Healthcare)
What does Green Hygienics Holdings Inc. do?
Green Hygienics Holdings Inc. is a development stage company focused on the cultivation and processing of industrial hemp for the extraction of cannabidiol (CBD). The company aims to capitalize on the growing demand for CBD products by cultivating hemp, extracting CBD, and potentially manufacturing and distributing CBD-infused products. As a development stage company, Green Hygienics is currently focused on establishing its operations, securing regulatory approvals, and building a sustainable business model in the competitive CBD market. The company was formerly known as Takedown Entertainment Inc. and changed its name in July 2012.
What do analysts say about GRYN stock?
There is currently no available analyst coverage for Green Hygienics Holdings Inc. (GRYN). This is typical for companies trading on the OTC Other tier, as they often have limited institutional interest and research coverage. The lack of analyst opinions makes it more challenging for investors to assess the company's prospects and valuation. Investors should conduct their own thorough due diligence and consider the risks associated with investing in a company with limited public information.
What are the main risks for GRYN?
The main risks for Green Hygienics Holdings Inc. include its development stage status, negative profitability, and the evolving regulatory landscape surrounding hemp and CBD. As a development stage company, Green Hygienics faces significant challenges in establishing its operations, securing funding, and achieving profitability. The company's negative profit and gross margins indicate financial instability. The evolving regulations surrounding hemp and CBD create uncertainty and could negatively impact the company's ability to operate and grow. Furthermore, the company faces intense competition in the CBD market, which could limit its ability to gain market share.
What are the key factors to evaluate for GRYN?
Green Hygienics Holdings Inc. (GRYN) holds an AI score of 43/100 (low). Not financial advice.
How frequently does GRYN data refresh on this page?
GRYN prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven GRYN's recent stock price performance?
Green Hygienics Holdings Inc. (GRYN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on a growing market (CBD). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider GRYN overvalued or undervalued right now?
Valuing Green Hygienics Holdings Inc. (GRYN) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying GRYN?
Before investing in Green Hygienics Holdings Inc. (GRYN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is limited due to the company's OTC status and development stage.
- Financial data is based on available information and may not be comprehensive.